Enhancing the Therapeutic Efficacy of Bortezomib in Cancer Therapy Using Polymeric Nanostructures

Author(s): Mitra Korani, Shahla Korani, Elham Zendehdel, Amin Reza Nikpoor, Mahmoud Reza Jaafari*, Hossein M. Orafai, Thomas P. Johnston, Amirhossein Sahebkar*.

Journal Name: Current Pharmaceutical Design

Volume 25 , Issue 46 , 2019


Bortezomib (VELCADE®) is a boronate peptide and first-in-class proteasome inhibitor serving an important role in degenerating several intracellular proteins. It is a reversible inhibitor of the 26S proteasome, with antitumor activity and antiproliferative properties. This agent principally exerts its antineoplastic effects by inhibiting key players in the nuclear factor κB (NFκB) pathway involved in cell proliferation, apoptosis, and angiogenesis. This medication is used in the management of multiple myeloma. However, more recently, it has been used as a therapeutic option for mantle cell lymphoma. While promising, bortezomib has limited clinical applications due to its adverse effects (e.g., hematotoxicity and peripheral neuropathy) and low effectiveness in solid tumors resulting from its poor penetration into such masses and suboptimal pharmacokinetic parameters. Other limitations to bortezomib include its low chemical stability and bioavailability, which can be overcome by using nanoparticles for its delivery. Nanoparticle delivery systems can facilitate the targeted delivery of chemotherapeutic agents in high doses to the target site, while sparing healthy tissues. Therefore, this drug delivery system has provided a solution to circumvent the limitations faced with the delivery of traditional cancer chemotherapeutic agents. Our aim in this review was to describe polymer-based nanocarriers that can be used for the delivery of bortezomib in cancer chemotherapy.

Keywords: Bortezomib, polymer-based nanocarriers, proteasome inhibitor, hematotoxicity, peripheral neuropathy, drug delivery system.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2019
Page: [4883 - 4892]
Pages: 10
DOI: 10.2174/1381612825666191106150018
Price: $58

Article Metrics

PDF: 8